Amedisys/ US0234361089 /
| 08/11/2024 21:59:58 | Chg. -0.08 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 96.72USD | -0.08% | 70,755 Turnover: 6.84 mill. |
-Bid Size: - | -Ask Size: - | 3.17 bill.USD | - | - |
Assets
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 28.1000 | 23.7000 | 18.4000 | 16 | 41.8000 | ||||||
| Intangible Assets | 64.7000 | 74.2000 | 111.2000 | 101.2000 | 102.7000 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 912.1910 | 1,205.2140 | 1,500.2840 | 1,587.2840 | 1,563.2350 | ||||||
| Inventories | - | - | - | - | - | ||||||
| Accounts Receivable | 237.5960 | 255.1450 | 274.9610 | 296.7850 | 313.3730 | ||||||
| Cash and Cash Equivalents | 30.3000 | 81.8000 | 42.7000 | 40.5000 | 126.5000 | ||||||
| Current Assets | 350.5540 | 361.9840 | 356.6840 | 388.9610 | 496.9350 | ||||||
| Total Assets | 1,262.7450 | 1,567.1980 | 1,856.9680 | 1,976.2450 | 2,060.1700 | ||||||
Liabilities
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 31.2590 | 42.6740 | 38.2170 | 43.7350 | 28.2370 | ||||||
| Long-term debt | 232.3000 | 204.5000 | 432.0750 | 419.4200 | 361.8620 | ||||||
| Liabilities to Banks | 232.3000 | - | - | - | - | ||||||
| Provisions | 37.7000 | - | - | - | - | ||||||
| Liabilities | 621.2320 | 756.4570 | 880.6450 | 869.6720 | 940.3870 | ||||||
| Share Capital | .0370 | .0380 | .0380 | .0380 | .0380 | ||||||
| Total Equity | 641.5130 | 810.7410 | 976.3230 | 1,106.5730 | 1,119.7830 | ||||||
| Minority Interests | 1.0630 | 1.5170 | 44.9720 | 55 | 53.2690 | ||||||
| Total liabilities equity | 1,262.7450 | 1,567.1980 | 1,856.9680 | 1,976.2450 | 2,060.1700 | ||||||
Income Statement
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 1,955.6000 | 2,071.5000 | 2,214.1000 | 2,223.2000 | 2,236.4000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 177.5000 | 219.3000 | 251.9000 | 180.8000 | 156.4000 | ||||||
| Interest Income | -14.4370 | -10.7460 | -9.4760 | -22.0500 | -28.0040 | ||||||
| Income Before Taxes | 170.4100 | 210.8190 | 280.2310 | 160.2440 | 39.6230 | ||||||
| Income Taxes | -42.5000 | -25.6000 | -70.1000 | -42.5000 | -50.6000 | ||||||
| Minority Interests Profit | -1.0740 | -1.5760 | -1.0940 | .9100 | 1.1890 | ||||||
| Net Income | 126.8000 | 183.6000 | 209.0720 | 118.6090 | -9.7470 | ||||||
Per Share
Cash Flow
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 202 | 288.9520 | 188.8930 | 133.2830 | 137.1880 | ||||||
| Cash Flow from Investing Activities | -352.9480 | -287.1080 | -281.6070 | -94.4860 | 35.0640 | ||||||
| Cash Flow from Financing | 227.2090 | -14.9770 | 55.1260 | -30.4330 | -87.5220 | ||||||
| Decrease / Increase in Cash | 76.2610 | -13.1330 | -37.5880 | 8.3640 | 84.7300 | ||||||
| Employees | 21,300 | - | - | - | - | ||||||
